{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2005"],"condition":["Colonic Neoplasms"],"disease":["Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2018907"],"location":["Sweden","Denmark"],"study_start_month":["8"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Enzastaurin for Patients With Metastatic Colorectal Cancer","description":"Enzastaurin given daily to participants with colorectal cancer who have Stage 4 disease and have not received prior chemotherapy for advanced colorectal cancer","dates":{"creation":"2005-08-15"},"accession":"2018907","cross_references":{"ClinicalTrials___gov":["NCT00192114"]}}